Global Infectious Respiratory Disease Diagnostics Market Research Report: Forecast (2023-2028)

Market Definition

Infectious respiratory diseases are generally caused by the spread of bacteria, viruses, or other pathogenic microbes through saliva & mucus when a person talks, sneezes, coughs, or even laughs, which can severely infect the respiratory system of an individual. With the growing cases of such diseases worldwide, especially among the elderly population, early & accurate diagnosis of the disease-causing pathogens is becoming increasingly crucial for administering appropriate therapies, initiating effective infection control measures, and minimizing the length of hospital stay. As a result, significant R&D investments are being directed toward introducing novel diagnostics & therapeutics to treat patients with infectious respiratory diseases.

Market Insights & Analysis: Global Infectious Respiratory Disease Diagnostics Market (2023-28)

The Global Infectious Respiratory Disease Diagnostics Market is expected to grow at a considerable CAGR during the forecast period, i.e., 2023-28. Respiratory infectious diseases like pneumonia, bronchitis, sinus infections, and laryngitis, among others, are the third leading cause of death and result in over 3 million deaths every year globally, cites WHO. The mounting prevalence of these illnesses owing to changing lifestyles, increasing adoption of advanced molecular therapeutics, rapidly rising elderly population, and various initiatives taken by governments & non-profit organizations across different countries worldwide toward minimizing the incidence of these diseases are the prime aspects projected to drive the Infectious Respiratory Disease Diagnostics Market through 2028.

Get Your Free Sample Report Now!

More and more diagnostics kits, assays, tubes, reagents, & other consumables are being utilized increasingly owing to the growing cancer incidence worldwide. Healthcare firms are substantially investing in introducing new products for infectious respiratory disease diagnostics, as well as in the commercialization of multiplex tests for the simultaneous diagnosis of Respiratory Syncytial Virus (RSV), Covid-19, & influenza, as these illnesses have similar symptoms.

• On 12 July 2021, Abbott Laboratories announced the launch of Panbio™ Covid-19 Antigen Self-Test in India for SARS-CoV-2 virus detection in adults & children with or without symptoms. This self-test that features a minimally invasive nasal swab and provides results in as early as 15 minutes without any instrumentation would cater to the ever-increased testing requirements of individuals at homes, offices, & clinics.

As multiplex testing allows for the simultaneous targeting of multiple genes, which helps minimize the time & cost incurred with traditional diagnostics, such as PCR, the need for its global commercialization is accelerating at a phenomenal pace. Additionally, the launch of new molecular diagnostic tests for SARS-CoV-2 detection, increasing utilization of self-test kits & point-of-care products, as well as rapid technological advancements that have enabled accurate, portable, & cost-effective diagnostics are other crucial aspects projected to stimulate the industry expansion, further enhancing the Global Infectious Respiratory Disease Diagnostics Market size over the coming years.

Global Infectious Respiratory Disease Diagnostics Market Driver:

The rise in the frequency of Respiratory Infectious Diseases drives Market Growth - The increasing geriatric population, the growing adoption of advanced molecular techniques due to The growing prevalence of respiratory diseases such as RSV, influenza, tuberculosis, etc., and government initiatives taken to reduce infectious disease incidents, drive the Market size. As per the analysis of the United States, around 4.2 million people are affected by pneumonia every year. To improve production to fulfill the surging demand in diagnostics for diagnosis of infectious respiratory diseases, some manufacturers are producing innovative techniques. For instance, in 2021, an InstaSwab utilizing 3D printing was introduced to meet the supply shortage of sample collection kits due to the COVID-19 pandemic.

Global Infectious Respiratory Disease Diagnostics Market Challenge:

The high cost associated with molecular diagnostic tests and the lack of skilled professionals hinder the Market - The high price associated with the molecular diagnostic tests used to diagnose infectious respiratory diseases is quite expensive such as RT-PCR, ELIZA, etc. To avoid contaminants and false-positive or false-negative results, a proper sterile place is needed to complete this process. Costly reagents have been used in the RT-PCR process, which helps to increase the test cost. Thus, hampering the market. The procedure of the tests required more precautions as the sample contained antigens. Due to this, molecular diagnostic tests require professional expertise, further responsible for the high cost of the diagnostic tests. Thus, this impeding the Global Infectious Respiratory Disease Diagnostics Market.

Global Infectious Respiratory Disease Diagnostics Market (2023-28): Segmentation Analysis 

The Global Infectious Respiratory Disease Diagnostics Market study from MarkNtel Advisors analyses the major trends in each sub-segment and includes predictions for the period 2023–2028 at the global, regional, and national levels. The market has been segmented in our analysis based on product type and sample type.

Based on Product Type:

• Instruments
• Consumables
• Services

Of these three, consumables dominated the Global Infectious Respiratory Disease Diagnostics Market. The same trend is likely over the coming few years, owing mainly to increased testing rates worldwide due to the ongoing pandemic. Consumables include assays & reagents that are used for performing IVD (In-vitro Diagnostic) tests for respiratory diseases and help significantly reduce ambiguity by providing reliable outcomes. As a result, the globally rising cases of infectious diseases and growing awareness among individuals of the importance of early disease detection in less time & costs shall continue promulgating the demand for consumables and, in turn, drive the Global Infectious Respiratory Disease Diagnostics Market through 2028.

Based on Sample Type:

• Nasopharyngeal Swabs (NPS)
• Anterior Nasal Region
• Blood
• Saliva

Here, Nasopharyngeal Swabs (NPS) dominated the market with the largest share in the previous years. It owes mainly to the advent of Covid-19 in 2020, which enabled an extensive utilization of NPS for conducting various tests, including but not limited to rapid antigen detection, direct fluorescent antibodies, and PCR (Polymerase Chain Reaction), among others. Undoubtedly, the pandemic has acted as the most prominent driving factor for NPS use across different countries worldwide, mainly due to the mandatory Covid-19 mass testing of individuals for travel & safety purposes. Several companies have exponentially increased their swab production & distribution capacities in order to cater to the heightened consumer demands. Until the entire global population gets vaccinated, NPS demand is expected to remain at its peak.

Hence, the mounting incidence of zoonotic diseases like MERS & SARD that severely affect the respiratory organs of individuals shall continue to augment the demand for NPS and, consequently, propel the growth of the Global Infectious Respiratory Disease Diagnostics Market in the coming years.

Global Infectious Respiratory Disease Diagnostics Market: Regional Projection

Geographically, the Global Infectious Respiratory Disease Diagnostics Market expands across:

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Based on the regions globally, Asia-Pacific is expected to attain a significant share of the Infectious Respiratory Disease Diagnostics Market during 2023-28. It owes to the mounting prevalence of respiratory illnesses like COPD (Chronic Obstructive Pulmonary Disease), tuberculosis, asthma, & sleep apnea, among others, coupled with ever-increased pollution levels, the rapidly surging tobacco consumption, increasing number of private-sector healthcare facilities, and rising elderly population levels.

Moreover, the growing affordability of people for advanced diagnostics, massive investments in healthcare infrastructure enhancements, increasing urbanization, active government efforts toward improving the availability of effective diagnostics for patients, burgeoning focus on improving screening rates, and growing applications in home care settings are other prominent aspects projected to stimulate regional market growth in the coming years.

Gain a Competitive Edge with Our Global Infectious Respiratory Disease Diagnostics Market Report

1. Global Infectious Respiratory Disease Diagnostics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size, share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. Global Infectious Respiratory Disease Diagnostics Market aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.